Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.BMC medical informatics and decision making · 2019
   Pooled it
2. Discrete Choice Experiments in Health Economics: Past, Present and Future.PharmacoEconomics · 2019
   Pooled it
3. Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
   Trial
4. Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia: A Multinational Discrete Choice Experiment.Patient preference and adherence · 2026
   Article
5. Attribute Preferences for Somatostatin Analogues in Neuroendocrine Tumours (NETs) Among Patients, Clinicians and Nurses in Australia.Cancer medicine · 2025
   Article
6. Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas.Applied health economics and health policy · 2025
   Article
7. A genuine need or nice to have? Understanding HTA representatives' perspectives on the use of patient preference data.International journal of technology assessment in health care · 2024
   Article
8. Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference study.International journal of technology assessment in health care · 2024
   Article
9. Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now?The patient · 2024
   Article
10. Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment.Patient preference and adherence · 2024
    Article
11. People With Diabetes and Caregivers Prefer Rescue Glucagon Treatment With a Wider Storage Temperature Range and a Nasal Administration, When Efficacy is Similar: A Discrete Choice Experiment in Spain.Journal of diabetes science and technology · 2023
    Article
12. Health utilities and willingness to pay in adult patients with coeliac disease in Hungary.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
13. Comparison of Preferences and Data Quality between Discrete Choice Experiments Conducted in Online and Face-to-Face Respondents.Medical decision making : an international journal of the Society for Medical Decision Making · 2023
    Article
14. DoesFrontiers in global women's health · 2023
    Article
15. Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article
16. Value Insider Season 1 Episode 2: How to Measure Quality of Life and Utility? (QoL) [Podcast].International journal of general medicine · 2022
    Article
17. The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing-Remitting Multiple Sclerosis.PharmacoEconomics · 2022
    Article
18. Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment Preferences.The patient · 2021
    Article
19. Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.Health economics review · 2021
    Article
20. Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study.The patient · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as